This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ConfometRx Research Foundation Announces 2013 GPCR Workshop

PALO ALTO, Calif., March 27, 2013 /PRNewswire-USNewswire/ -- ConfometRx Research Foundation is pleased to announce the 2013 GPCR Workshop to be held at Hyatt Regency, Maui Dec 1-5, 2013.  The Royal Swedish Academy of Sciences called global attention to the significance of G protein coupled receptors (GPCRs) by awarding the 2012 Nobel Prize in Chemistry to two pioneers in the field.  GPCRs mediate the senses of sight, olfaction and taste, as well as the physiologic responses to the majority of hormones and neurotransmitters in the human body. As such GPCRs are the targets for nearly 50% of all marketed drugs, and are potential targets for many unmet medical needs. 

The goals of the workshop are to bring together scientists from academia and the pharmaceutical and biotechnology industries to discuss the most challenging problems in the GPCR field and explore new ways to work together to find solutions. The workshop will encourage mutual sharing of ongoing research results, both successes and failures, so as to facilitate progress in the development of more effective therapeutics for G protein coupled receptor targets.

The format for this workshop will encourage a free flow of ideas centered around key problems facing GPCR drug discovery, and a discussion of what different investigators have tried, what has worked, and what has failed. Morning sessions will consist of presentations from invited speakers covering a range of topics. Evening interactive sessions will provide a forum for attendees to present and discuss their latest research. The conference will follow the principles of the Gordon Research Conferences, where the participants will hold data and ideas discussed at the workshop in confidence.

The co-organizers of the workshop include the founders of the ConfometRx Research Foundation, Tong Sun and Brian Kobilka, who are also co-founders of ConfometRx, a sponsor of the workshop, and Arthur Christopoulos and Patrick Sexton of Monash Institute of Pharmaceutical Sciences, Melbourne, Australia, also a workshop sponsor.  The environment of the workshop is informal and dynamic, and conducive to a free flow of ideas.  We encourage the participation of pharmaceutical companies through sponsorship and participation in the workshop.  Please visit the website for information and registration: www.gpcrworkshop.com.

SOURCE ConfometRx

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs